These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34673818)

  • 1. SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data.
    Karapetyan S; Schneider A; Linde K; Donnachie E; Hapfelmeier A
    PLoS One; 2021; 16(10):e0258914. PubMed ID: 34673818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I).
    Maddaloni E; D'Onofrio L; Alessandri F; Mignogna C; Leto G; Coraggio L; Sterpetti S; Pascarella G; Mezzaroma I; Lichtner M; Pozzilli P; Agrò FE; Rocco M; Pugliese F; Mastroianni CM; Buzzetti R;
    Diabetes Res Clin Pract; 2020 Nov; 169():108454. PubMed ID: 32971157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.
    Gómez Antúnez M; Muiño Míguez A; Bendala Estrada AD; Maestro de la Calle G; Monge Monge D; Boixeda R; Ena J; Mella Pérez C; Anton Santos JM; Lumbreras Bermejo C;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3433-3445. PubMed ID: 33447021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.
    Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE
    Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between chronic kidney disease and COVID-19-related mortality in New York.
    Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
    World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Islam MZ; Riaz BK; Islam ANMS; Khanam F; Akhter J; Choudhury R; Farhana N; Jahan NA; Uddin MJ; Efa SS
    Epidemiol Infect; 2020 Oct; 148():e263. PubMed ID: 33115547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.
    Khan MS; Dogra R; Miriyala LKV; Salman FNU; Ishtiaq R; Patti DK; Kumar A; Sandho G; Jacob K; Luthra K; Sharma R; Ravikumar R; Edara D; Pittampalli S; Sood D; Khatri V; Mahajan V; Avasthi S; Auoad A; Katragadda S
    PLoS One; 2021; 16(4):e0250400. PubMed ID: 33886663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Challenging Interaction of Chronic Kidney Disease With Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors.
    Panahi MH; Hadaegh F; Yavari P; Kazempour-Ardebili S; Mehrabi Y; Azizi F; Khalili D
    Iran J Kidney Dis; 2016 Sep; 10(5):274-281. PubMed ID: 27721225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
    PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
    Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results.
    Broseta JJ; Rodríguez-Espinosa D; Cuadrado E; Guillén-Olmos E; Hermida E; Montagud-Marrahi E; Rodas L; Vera M; Fontseré N; Arias M; Cases A; Maduell F
    Blood Purif; 2021; 50(4-5):531-538. PubMed ID: 33352569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.
    Pilgram L; Eberwein L; Wille K; Koehler FC; Stecher M; Rieg S; Kielstein JT; Jakob CEM; Rüthrich M; Burst V; Prasser F; Borgmann S; Müller RU; Lanznaster J; Isberner N; Tometten L; Dolff S;
    Infection; 2021 Aug; 49(4):725-737. PubMed ID: 33851328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computing SARS-CoV-2 Infection Risk From Symptoms, Imaging, and Test Data: Diagnostic Model Development.
    D'Ambrosia C; Christensen H; Aronoff-Spencer E
    J Med Internet Res; 2020 Dec; 22(12):e24478. PubMed ID: 33301417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Severe COVID-19 Among Workers and Their Household Members.
    Selden TM; Berdahl TA
    JAMA Intern Med; 2021 Jan; 181(1):120-122. PubMed ID: 33165502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.